Filling the need for trusted information on national health issues…

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

The Henry J. Kaiser Family Foundation

Inexpensive Blood-Clotting Drug Reduces Postpartum Hemorrhage Among New Mothers, Study Shows

Humanosphere: Drug effective against leading cause of maternal death, study finds “An inexpensive and widely available drug could save the lives of thousands of women who die each year from severe bleeding after childbirth — the leading cause of maternal death worldwide, according to new study…” (Nikolau, 4/26). New York…

News Summary Read More
The Henry J. Kaiser Family Foundation

G20 Nations Must Make More Effort To Prevent Disease Among Vulnerable Groups Within Own Borders

Devex: Opinion: G20 leadership on tackling disease would save lives and money Alan Donnelly, executive chairman of Sovereign Strategy; Willo Brock, senior vice president of external affairs for the Global Alliance for TB Drug Development; and Claire Wingfield, senior policy officer with the advocacy and public policy program at PATH…

News Summary Read More
The Henry J. Kaiser Family Foundation

Global Health Experts Call For Greater Focus On Implementation Science, System Innovations During Skoll World Forum

Devex: A call for implementation science and systems innovation in global health “…[Larry] Brilliant is chairman of the Skoll Global Threats Fund, to which philanthropist Jeff Skoll just announced he would give $50 million for a program focused on pandemics. Spanning smallpox, Ebola, polio, and threats that may be looming,…

News Summary Read More
The Henry J. Kaiser Family Foundation

Devex Interviews Peter Piot About ‘Global Health 2.0,’ Challenges To Research, Training

Devex: Q&A: Peter Piot on grand challenges in research, education, and training for global health “As Peter Piot considers the future of global health, he has decades of experience to draw on, spanning back to before the term even existed. So when he talks about global health 2.0, as he…

News Summary Read More
The Henry J. Kaiser Family Foundation

China Becoming Key Player In Global Health

Forbes: How China Is On Course To Unseat U.S. As The Next Leader In Global Heath “Beijing and Washington have opposing views on nearly everything from North Korea’s nuclear development program to trade and development in the South China Sea. But one area of collaboration is emerging as a potential…

News Summary Read More
The Henry J. Kaiser Family Foundation

News Outlets Continue To Report On 2018 Malaria Vaccine Pilot Program Rollout

Al Jazeera: WHO: Malaria vaccine to be ‘real life’ tested in Africa “The world’s first malaria vaccine will be available in selected areas of Ghana, Kenya, and Malawi from 2018, according to the World Health Organization (WHO)…” (4/24). CNN: First malaria vaccine to be widely tested in Africa next year…

News Summary Read More
The Henry J. Kaiser Family Foundation

Financial Times Special Report Focuses On Malaria

Financial Times: FT Health: Malaria “We look at the latest genetic breakthroughs, new medicines, and the prospects for an anti-malarial vaccine, a potential role for GM mosquitoes, and other leading features of the advances and continuing fight against the disease…” (Multiple authors, 4/24).

News Summary Read More
The Henry J. Kaiser Family Foundation

U.S. National Academy Of Medicine Panel Raises Concerns Over Experimental Ebola Vaccine Trial Results

Wall Street Journal: Vaunted Ebola Vaccine Faces Questions “…In December, doctors from the World Health Organization, Doctors Without Borders, and other groups reported in the British medical journal The Lancet that a vaccine from Merck & Co. and NewLink Genetics Corp. tested during the outbreak proved to be 100 percent…

News Summary Read More
The Henry J. Kaiser Family Foundation

U.S. Army To Move Ahead With Exclusive Licensing Of Experimental Zika Vaccine To Sanofi Pasteur

STAT: Army rejects request to deny Sanofi an exclusive license for a Zika vaccine “The U.S. Army is proceeding with plans to grant Sanofi Pasteur an exclusive license to develop a vaccine for the Zika virus, despite concerns among some lawmakers and advocacy groups that the product may be priced…

News Summary Read More
The Henry J. Kaiser Family Foundation

Lessons From Ebola Highlight ‘Vital Centrality Of Vaccines’ As Tool For Disease Prevention, Control

Thomson Reuters Foundation: New partnerships needed after Ebola’s hard lessons J. Stephen Morrison, senior vice president and director, and Chris Millard, program manager and research associate, both at the Center for Strategic and International Studies’ Global Health Policy Center “…[W]hile today the epidemic has been largely contained, Ebola taught us…

News Summary Read More

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.